Sarah Zielsdorf, MD, MS - Rheumatoid Arthritis (2018 Conference) (LDN, low dose naltrexone)

Dr Sarah Zielsdorf shares her presentation on Rheumatoid Arthritis (RA) at The LDN 2018 Conference.

In this presentation Dr Zielsdorf presents a fascinating case study of a patient with Rheumatoid Arthritis (RA) detailing her experience with symptoms, statistics and her own wealth of medical experience.

p>

Sarah Zielsdorf, MD, 2019 Pain Seminar in CT (LDN 2019 Pain Seminar) from LDN Research Trust on Vimeo.

Dr Sarah Zielsdorf shares her presentation on Pain at The LDN 2019 Pain Seminar.

Jill Cottel, MD - Treating the Zebras in Primary Care (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Cottel shares case studies of patients:

36 year old woman with Ehlers-Danlos Syndrome. This lady was started on Low Dose Naltrexone (LDN) at 1.5mg, increased to 3 mg and found she lost her earlier improvement but on going down to a much lower dose she improved significantly. 

Jarred Younger, PhD - The Ten Most Important Fibromyalgia Discoveries of 2016 and 2017 (2017 Conference) (LDN, low dose naltrexone)

People with rheumatological conditions are much more likely to have fibromyalgia than the general population, Lupus in particular was indicated to be the most likely rheumatological condition where fibromyalgia was also present. 

“Skip” Lenz, PharmD - Report on LDN Study (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Lenz's LDN Study Presentation

“Report on the Longitudinal Study of the Effects, Side Effects & Interaction of Naltrexone in Low Dose”.